Author:
Nguyen Truong Phan-Xuan,Roytrakul Sittiruk,Buranapraditkun Supranee,Shuangshoti Shanop,Kitkumthorn Nakarin,Keelawat Somboon
Abstract
AbstractDiagnosing encapsulated follicular-patterned thyroid tumors like Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma (IEFVPTC), Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP), and Well-Differentiated Tumor of Uncertain Malignant Potential (WDT-UMP) remains challenging due to their morphological and molecular similarities. This study aimed to investigate the protein distinctions among these three thyroid tumors and discover biological tumorigenesis through proteomic analysis. We employed total shotgun proteome analysis allowing to discover the quantitative expression of over 1398 proteins from 12 normal thyroid tissues, 13 IEFVPTC, 11 NIFTP, and 10 WDT-UMP. Principal component analysis revealed a distinct separation of IEFVPTC and normal tissue samples, distinguishing them from the low-risk tumor group (NIFTP and WDT-UMP). IEFVPTC exhibited the highest number of differentially expressed proteins (DEPs) compared to the other tumors. No discriminatory proteins between NIFTP and WDT-UMP were identified. Moreover, DEPs in IEFVPTC were significantly associated with thyroid tumor progression pathways. Certain hub genes linked to the response of immune checkpoint inhibitor therapy, revealing the potential predictor of prognosis. In conclusion, the proteomic profile of IEFVPTC differs from that of low-risk tumors. These findings may provide valuable insights into tumor biology and offer a basis for developing novel therapeutic strategies for follicular-patterned thyroid neoplasms.
Funder
Ratchadapiseksompotch and Ratchadapisek Research Funds Type I
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71, 209–249. https://doi.org/10.3322/caac.21660 (2021).
2. Jahanbani, I., Al-Abdallah, A., Ali, R. H., Al-Brahim, N. & Mojiminiyi, O. Discriminatory miRNAs for the management of papillary thyroid carcinoma and noninvasive follicular thyroid neoplasms with papillary-like nuclear features. Thyroid 28, 319–327. https://doi.org/10.1089/thy.2017.0127 (2018).
3. WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours, vol. 8. 5th edn. (International Agency for Research on Cancer, Lyon, France, 2022) https://tumourclassification.iarc.who.int. Accessed 10 Feb 2023.
4. Liu, Z. et al. Interobserver and intraobserver variation in the morphological evaluation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice. Pathol. Int. 69, 202–210. https://doi.org/10.1111/pin.12779 (2019).
5. Elsers, D. A., Hussein, M. R. A., Osman, M. H., Mohamed, G. A. & Hosny, G. Challenge in the pathological diagnosis of the follicular—patterned thyroid lesions. Asian Pac. J. Cancer Prevent. 22, 3365–3376. https://doi.org/10.31557/apjcp.2021.22.10.3365 (2021).